Clinical Solutions Innovating Medical Research aka CSI Medical Research Pte Ltd (CSI MR) is a contract research organisation (CRO) providing innovative, cost-effective, and efficient clinical solutions in Singapore since 2017. We believe in implementing innovative automation by focusing on patient safety and care in clinical trials.

​​

CSI MR has extensive industry experience and knowledge of local practices, regional ethics, regulatory requirements, and site operations, making us your preferred strategic partner. We hope to aid more companies to confidently enter the Southeast Asian market with us for innovative and cost-effective solutions.

​

CSI MR has set up its entities in Malaysia (2020) and Australia (2022). We aim to be recognised as SEA’s most trustworthy CRO by 2025 with the focus on delivering our many services in clinical trials within Asia–Pacific Countries.

​

On the 12th of January 2024, CSI MR was acquired by Clinchoice, a leading global CRO. Via this acquisition and merger, Clinchoice further broadens its global footprint and full-service capabilities in more than 30 countries throughout Asia, Europe and North America.  

​

For more information, email us at BD@csimedicalresearch.com.